|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer|
|Dong-Soo Lee, Yeon-Sil Kim, Jin-Hyoung Kang, Sang-Nam Lee, Young-Kyoun Kim, Myung-Im Ahn, Dae-Hee Han, Ie-Ryung Yoo, Young-Pil Wang, Jae-Gil Park, Sei-Chul Yoon, Hong-Seok Jang, Byung-Oak Choi|
|Cancer Research and Treatment. 2011;43(1):32-41. Published online 2011 March 31 DOI: https://doi.org/10.4143/crt.2011.43.1.32|
Concurrent chemoradiation for stage III non small cell lung cancer: Present results and future prospects
Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): from cisplatin alone to cisplatin + etoposide
Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group Protocol 91-06
Should brain imaging be included in staging prior to radical concurrent chemoradiation for non-small cell lung cancer (NSCLC) patients in the UK?
Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer
A Retrospective Study of Concurrent Chemoradiation using Mitomycin, Vinblastine and Cisplatin Chemotherapy for Non-small Cell Lung Cancer
Hypofractionated Concurrent Chemoradiation in Stage III Non-small Cell Lung Cancer: Does Planning Target Volume Size Correlate With Prognosis?
Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence
Pericardial effusion as clinical first appearance of non-small cell lung cancer: Prognostic value and therapy
Pre-treatment prognostic factors in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy
|This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.|